Apolipoprotein A-I Deficiency
- 1 December 1995
- journal article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 15 (12) , 2157-2164
- https://doi.org/10.1161/01.atv.15.12.2157
Abstract
Abstract Familial HDL deficiencies are associated with variable susceptibility to premature coronary heart disease, but the mechanism underlying this association remains poorly understood. Three homozygotes with isolated complete apo A-I deficiency caused by an autosomal codominant apo A-I Q[−2]X mutation and one heterozygote developed coronary heart disease before age 40 years. We characterized the effects of this mutation on lipoprotein metabolism. LDL FC, phospholipid, and apo B were all significantly higher in homozygotes than in heterozygotes. The HDLs of the heterozygotes were apo A-I poor relative to apo A-II. Lecithin-cholesterol acyltransferase activity was 59% lower in homozygotes than in normal subjects or heterozygotes. Cholesteryl ester transfer activity was increased in a homozygote compared with a normolipidemic control subject. Postprandial lipid metabolism was studied in one homozygote and one heterozygote. Postprandial TG response in the homozygote was significantly exaggerated, while residual plasma HDL level remained unaffected. The homozygote also had delayed clearance of retinyl ester, a marker of chylomicron remnant metabolism. Thus, homozygosity and heterozygosity for apo A-I Q[−2]X are associated with qualitative, as well as quantitative, disturbances in plasma HDLs, LDLs, lipid-modifying enzyme activities, and postprandial retinyl ester metabolism. The observed elevation of atherogenic lipoproteins and reduction in antiatherogenic lipoproteins in the affected members of the apo A-I Q[−2]X kindred are consistent with the primary deficiency in apo A-I having pleiotropic effects that markedly enhance susceptibility for coronary heart disease.Keywords
This publication has 26 references indexed in Scilit:
- Characterization of apolipoprotein A-I- and A-II-containing lipoproteins in a new case of high density lipoprotein deficiency resembling Tangier disease and their effects on intracellular cholesterol efflux.Journal of Clinical Investigation, 1993
- Cholesterol esterification by lecithin-cholesterol acyltransferase in A-I-free plasmaBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1988
- Lecithin:cholesterol acyltransferase in familial HDL deficiency (Tangier disease)Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1988
- Relation of serum total cholesterol and high-density lipoprotein cholesterol percentage to the incidence of definite coronary events: Twenty-year follow-up of the donolo-Tel Aviv prospective coronary artery disease studyThe American Journal of Cardiology, 1987
- Deficiency of apolipoproteins a-i and c-iii and severe coronary heart diseaseClinical Cardiology, 1986
- Intestinal Synthesis, Secretion, and Transport of LipoproteinsAnnual Review of Physiology, 1983
- Evidence that lecithin: Cholesterol acyltransferase acts on both high-density and low-density lipoproteinsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1983
- Familial Deficiency of Apolipoproteins A-I and C-III and Precocious Coronary-Artery DiseaseNew England Journal of Medicine, 1982
- Identification of lipoprotein families in a variant of human plasma apolipoprotein A deficiencyScandinavian Journal of Clinical and Laboratory Investigation, 1979
- Evidence for a Common, Saturable, Triglyceride Removal Mechanism for Chylomicrons and Very Low Density Lipoproteins in ManJournal of Clinical Investigation, 1973